IP Library Granted Patent US 9,119,898
Granted Patent B2
US 9,119,898 · App. 13/125,595 · Granted Sep 1, 2015

Medical implant including a 3D mesh of oxidized cellulose and a collagen sponge

Inventors: Yves Bayon (Lyons, FR); Sébastien Ladet (Lyons, FR); Olivier Lefranc (Chatillon sur Chalaronne, FR); Philippe Gravagna (Irigny, FR)
Assignee: Sofradim Production
A61L27/24A61L27/20A61L27/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,119,898
App. No.
13/125,595
Granted
Sep 1, 2015
Kind
B2
Abstract

The present invention relates to A bioresorbable implant comprising: a bioresorbable porous layer including a biopolymer foam and defining first pores, a bioresorbable porous three-dimensional mesh made from a microbial cellulose and defining second pores, wherein the bioresorbable porous layer is disposed in the bioresorbable porous three-dimensional mesh. The invention also relates to a method of making a bioresorbable implant.

Claims (23)

1. A bioresorbable implant comprising:

a bioresorbable porous layer including a biopolymer foam defining first pores, and a three-dimensional density from about 30 mg collagen/cm 3 to about 150 mg collagen cm 3 ,

a bioresorbable porous three-dimensional mesh made from a microbial cellulose having a thickness of about 0.1 cm to about 3 cm, and defining second pores from about 0.5 mm to about 5 mm, wherein the bioresorbable porous layer is disposed in the bioresorbable porous three-dimensional mesh, and

a non-porous film applied to the bioresorbable porous three-dimensional mesh including the bioresorbable porous layer.

2. The bioresorbable implant of claim 1 , wherein the first and second pores are at least partially interconnected with one another.

3. The bioresorbable implant of claim 1 , wherein the microbial cellulose is derived from Acetobacter xylinum as wet pellicles or films.

4. The bioresorbable implant of claim 1 , wherein the microbial cellulose is oxidized.

5. The bioresorbable implant of claim 1 , wherein the biopolymer foam comprises pores having a size of from about 10 μm to about 500 μm.

6. The bioresorbable implant of claim 1 , wherein the biopolymer foam is from about 0.2 to about 1.5 cm thick.

7. The bioresorbable implant of claim 1 , further comprising a bioactive agent.

8. The bioresorbable implant of claim 1 , wherein the microbial cellulose mesh displays a minimal elongation at break in at least one direction of about 50 N.

9. The bioresorbable implant of claim 1 , wherein the microbial cellulose has a thickness of about 0.2 cm to about 1 cm.

10. The bioresorbable implant of claim 1 , wherein the non-porous film is positioned on a first side of the implant to reduce postsurgical adhesions and the porous layer is positioned on a second side opposite the first side of the implant to allow for cell colonization.

11. The bioresorbable implant of claim 1 , wherein the non-porous layer is from about 30 μms to about 75 μms thick and the porous layer is from about 0.3 cms to about 1.2 cms thick.

12. A method of making a bioresorbable implant, comprising:

adding an aqueous acid solution or suspension of collagen to a bioresorbable porous three-dimensional mesh made from a microbial cellulose having a thickness of about 0.1 cm to about 3 cm, and defining second pores from about 0.5 mm to about 5 mm,

lyophilizing the solution to create a bioresorbable foam layer in the bioresorbable porous three-dimensional mesh, wherein the bioresorbable foam layer includes a three-dimensional density from about 30 mg collagen/cm 3 to about 150 mg collagen/cm 3 , and

applying a non porous layer to the bioresorbable porous three-dimensional mesh that has been filled with the bioresorbable foam layer.

13. The method of claim 12 , wherein the biopolymer foam layer is cross-linked.

14. The method of claim 12 , wherein the non porous layer comprises a collagenic constituent.

15. The method of claim 12 , wherein the microbial cellulose has a thickness of about 0.2 cm to about 1 cm.

16. The method of claim 12 , wherein the non-porous film is positioned on a first side of the implant to reduce postsurgical adhesions and the porous layer is positioned on a second side opposite the first side of the implant to allow for cell colonization.

17. The method of claim 12 , wherein the non-porous layer is from about 30 μmsto about 75 μms thick and the porous layer is from about 0.3 cms to about 1.2 cms thick.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2011
From: BAYON, YVES, MR; LADET, SEBASTIEN, MR; LEFRANC, OLIVIER, MR.; GRAVAGNA, PHILIPPE, MR
To: SOFRADIM PRODUCTION
Reel/Frame 026597/0997 →
Continuity (2)
Provisional Application 61112306 · Nov 7, 2008
Related Publication 20110264119A1 · Oct 27, 2011